التفاصيل البيبلوغرافية
| العنوان: |
Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications. |
| المؤلفون: |
Yoshida, Yuji, Ogata, Atsushi, Kang, Sujin, Ebina, Kousuke, Shi, Kenrin, Nojima, Satoshi, Kimura, Tetsuya, Ito, Daisuke, Morimoto, Keiko, Nishide, Masayuki, Hosokawa, Takashi, Hirano, Toru, Shima, Yoshihito, Narazaki, Masashi, Tsuboi, Hideki, Saeki, Yukihiko, Tomita, Tetsuya, Tanaka, Toshio, Kumanogoh, Atsushi |
| المصدر: |
Arthritis & Rheumatology; Jun2015, Vol. 67 Issue 6, p1481-1490, 10p |
| مصطلحات موضوعية: |
THERAPEUTIC use of biochemical markers, ACADEMIC medical centers, ANIMAL experimentation, BLOOD testing, STATISTICAL correlation, CYTOKINES, ENZYME-linked immunosorbent assay, FLOW cytometry, IMMUNOHISTOCHEMISTRY, INFLAMMATION, MICE, POLYMERASE chain reaction, RESEARCH funding, RHEUMATOID arthritis, SEVERITY of illness index, REVERSE transcriptase polymerase chain reaction, MANN Whitney U Test, KRUSKAL-Wallis Test |
| مصطلحات جغرافية: |
JAPAN |
| مستخلص: |
Objective Semaphorin 4D (Sema4D)/CD100 has pleiotropic roles in immune activation, angiogenesis, bone metabolism, and neural development. We undertook this study to investigate the role of Sema4D in rheumatoid arthritis (RA). Methods Soluble Sema4D (sSema4D) levels in serum and synovial fluid were analyzed by enzyme-linked immunosorbent assay. Cell surface expression and transcripts of Sema4D were analyzed in peripheral blood cells from RA patients, and immunohistochemical staining of Sema4D was performed in RA synovium. Generation of sSema4D was evaluated in an ADAMTS-4-treated monocytic cell line (THP-1 cells). The efficacy of anti-Sema4D antibody was evaluated in mice with collagen-induced arthritis (CIA). Results Levels of sSema4D were elevated in both serum and synovial fluid from RA patients, and disease activity markers were correlated with serum sSema4D levels. Sema4D-expressing cells also accumulated in RA synovium. Cell surface levels of Sema4D on CD3+ and CD14+ cells from RA patients were reduced, although levels of Sema4D transcripts were unchanged. In addition, ADAMTS-4 cleaved cell surface Sema4D to generate sSema4D in THP-1 cells. Soluble Sema4D induced tumor necrosis factor α (TNFα) and interleukin-6 (IL-6) production from CD14+ monocytes. IL-6 and TNFα induced ADAMTS-4 expression in synovial cells. Treatment with an anti-Sema4D antibody suppressed arthritis and reduced proinflammatory cytokine production in CIA. Conclusion A positive feedback loop involving sSema4D/IL-6 and TNFα/ADAMTS-4 may contribute to the pathogenesis of RA. The inhibition of arthritis by anti-Sema4D antibody suggests that Sema4D represents a potential therapeutic target for RA. [ABSTRACT FROM AUTHOR] |
|
Copyright of Arthritis & Rheumatology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder